drugset / Trial / NCT00007033

Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease

NCT00007033

Treatment

Summary

OBJECTIVES: I. Determine the role of magnesium deficiency in the pathogenesis of decreased serum vitamin D and reduced bone density in children with chronic cholestatic liver disease.

Timeline

Start
2000-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject MAGNESIUM GLUCONATE ANHYDROUS Small molecule Oral
Subject Magnesium Sulfate Other / unclassified Intravenous